Cargando…

Efficacy, safety and cost-effectiveness of insulin sensitizers as add-on therapy in metabolic syndrome in patients with secondary sulfonylurea failure: A comparative study

OBJECTIVES: Prevalence of metabolic syndrome (MS) is ~25% and it is currently becoming prevalent in children also. India is estimated to have the maximum number of patients of MS in the world. As insulin resistance is an integral part of MS and the rate of secondary sulfonylurea failure (SSUF) is al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahajan, Rajiv, Gupta, Anita, Gupta, Rajinder Singh, Gupta, Kapil
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043342/ https://www.ncbi.nlm.nih.gov/pubmed/21350615 http://dx.doi.org/10.4103/0976-500X.72349

Ejemplares similares

Coronary risk factors in maintenance hemodialysis patients: Who is the culprit – hemodialysis or chronic renal failure?
por: Gupta, Kapil, et al.
Publicado: (2011)

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy
por: Lorenzoni, Valentina, et al.
Publicado: (2017)

Effect of preeclampsia on insulin sensitivity
por: Sinha, Smita, et al.
Publicado: (2014)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Efficacy, Safety, and Cost Evaluation of the Topical Luliconazole Therapy versus Topical Clotrimazole Therapy in Patients with Localized Dermatophytosis in a Tertiary Care Hospital: An Observational Study
por: Kaur, Mandeep, et al.
Publicado: (2020)

Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
por: Chen, Ying-Hua, et al.
Publicado: (2019)

Cytochrome modulation decreases the risk of cataract: Is the basic hypothesis flawless?
por: Mahajan, Rajiv, et al.
Publicado: (2009)

Adaptive design clinical trials: Methodology, challenges and prospect
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Food and drug administration’s critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Prevention and management of type 2 diabetes: Potential role of genomics
por: Mahajan, Rajiv, et al.
Publicado: (2014)

Evaluation of orientation program for fresh MBBS entrants: Faculty and students’ perspectives
por: Mahajan, Rajiv, et al.
Publicado: (2015)

Applications and Diagnostic Potential of Dried Blood Spots
por: Gupta, Kapil, et al.
Publicado: (2018)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Possible role of elevated serum testosterone in pathogenesis of renal stone formation
por: Gupta, Kapil, et al.
Publicado: (2016)

Introduction and Implementation of Early Clinical Exposure in Undergraduate Medical Training to Enhance Learning
por: Gupta, Kapil, et al.
Publicado: (2020)

Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study
por: Hougen, Ingrid, et al.
Publicado: (2021)

Antidiabetic Effects of Add-On Gynostemma pentaphyllum Extract Therapy with Sulfonylureas in Type 2 Diabetic Patients
por: Huyen, V. T. T., et al.
Publicado: (2012)

Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
por: Roumie, Christianne L., et al.
Publicado: (2017)

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin
por: Kim, Ye An, et al.
Publicado: (2015)

Optical control of insulin release using a photoswitchable sulfonylurea
por: Broichhagen, Johannes, et al.
Publicado: (2014)

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
por: Shin, Yujin, et al.
Publicado: (2020)

Evaluation of Aro-Tal-AST Complex Protein as a Marker for Differential Diagnosis of Mycobacterium Avium Infection
por: Gupta, Kapil, et al.
Publicado: (2011)

Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release
por: Walczewska-Szewc, Katarzyna, et al.
Publicado: (2021)

Safety and Efficacy of Ultra-Low-Dose Intracavernosal Adrenaline for Intraoperative Penile Erection in Transurethral Surgeries under Spinal Anesthesia
por: Gupta, Rahul, et al.
Publicado: (2020)

Assessment of insulin sensitivity/resistance
por: Gutch, Manish, et al.
Publicado: (2015)

Effect of clobazam as add-on antiepileptic drug in patients with epilepsy
por: Joshi, Rupa, et al.
Publicado: (2014)

Gamma radiation improves AD pathogenesis in APP/PS1 mouse model by potentiating insulin sensitivity
por: Khandelwal, Mayuri, et al.
Publicado: (2020)

Efficacy and safety of add on low-dose mirtazapine in depression
por: Matreja, Prithpal S., et al.
Publicado: (2012)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin
por: Saito, Daisuke, et al.
Publicado: (2017)

Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment
por: Yang, Yeoree, et al.
Publicado: (2016)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Contemporary use of ultrasonic versus standard electrosurgical dissection in laparoscopic nephrectomy: Safety, efficacy and cost
por: Arvind, Nand Kishore, et al.
Publicado: (2018)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
por: Neumiller, Joshua J.
Publicado: (2014)

Insulin-derived amyloidosis
por: Gupta, Yashdeep, et al.
Publicado: (2015)

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
por: Gotoh, Daisuke, et al.
Publicado: (2022)

Lixisenatide as add-on therapy to basal insulin
por: Brown, Dominique Xavier, et al.
Publicado: (2013)

Insulin Sensitivity among Indian Diabetics
por: Gupta, Nitya Nand, et al.
Publicado: (1947)

Cannot write session to /tmp/vufind_sessions/sess_0tufs8rq6cn7r096hrapt9uvcr